Evidence map›Paper›PMID 34955658›Full record

ArticleMedical devices (Auckland, N.Z.)2021

Mobile Cardiac Outpatient Telemetry Patch vs Implantable Loop Recorder in Cryptogenic Stroke Patients in the US - Cost-Minimization Model.

Goran Medic, Nikos Kotsopoulos, Mark P Connolly, Jennifer Lavelle, Vincent Norlock, Manish Wadhwa, Belinda A Mohr, Wayne M Derkac

Open access · goldAbstract read
In one paragraph

Article in Medical devices (Auckland, N.Z.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Goran MedicChief Medical Office, Philips Healthcare, Eindhoven, Netherlands.ORCID 0000-0002-2440-8743
Nikos KotsopoulosGlobal Market Access Solutions LLC, Charlotte, NC, USA.
Mark P ConnollyDepartment of Pharmacy, University of Groningen, Groningen, Netherlands.ORCID 0000-0002-1886-745X
Jennifer LavelleBioTelemetry, Inc., A Philips Company, Malvern, PA, USA.
Vincent NorlockBioTelemetry, Inc., A Philips Company, Malvern, PA, USA.
Manish WadhwaBioTelemetry, Inc., A Philips Company, Malvern, PA, USA.
Belinda A MohrChief Medical Office, Philips, Cambridge, MA, USA.
Wayne M DerkacBioTelemetry, Inc., A Philips Company, Malvern, PA, USA.
BioTelemetry (United States) · USAccess to Wholistic and Productive Living Institute · USNXP (Netherlands) · NLPhilips (United States) · USUniversity of Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aim of this study was to compare costs and outcomes of mobile cardiac outpatient telemetry (MCOT) patch followed by implantable loop recorder (ILR) compared to ILR alone in cryptogenic stroke patients from the US health-care payors' perspective. PATIENTS AND

methodsA quantitative decision tree cost-minimization simulation model was developed. Eligible patients were 18 years of age or older and were diagnosed with having a cryptogenic stroke, without previously documented atrial fibrillation (AF). All patients were assigned first to one then to the alternative monitoring strategies. Following AF detection, patients were initiated on oral anticoagulants (OAC). The model assessed direct costs for one year attributed to MCOT patch followed by ILR or ILR alone using a monitoring duration of 30 days post-cryptogenic stroke.

resultsIn the base case modeling, the MCOT patch arm detected 4.6 more patients with AFs compared to the ILR alone arm in a cohort of 1000 patients (209 vs 45 patients with detected AFs, respectively). Using MCOT patch followed by ILR in half of the patients initially undiagnosed with AF leads to significant cost savings of US$4,083,214 compared to ILR alone in a cohort of 1000 patients. Cost per patient with detected AF was significantly lower in the MCOT patch arm $29,598 vs $228,507 in the ILR only arm.

conclusionAn initial strategy of 30-day electrocardiogram (ECG) monitoring with MCOT patch in diagnosis of AF in cryptogenic stroke patients realizes significant cost-savings compared to proceeding directly to ILR only. Almost 8 times lower costs were achieved with improved detection rates and reduction of secondary stroke risk due to new anticoagulant use in subjects with MCOT patch detected AF. These results strengthen emerging recommendations for prolonged ECG monitoring in secondary stroke prevention.

Indexed as

ambulatory cardiac monitoringatrial fibrillationeconomic evaluationelectrocardiographyHoltersecondary prevention

Identifiers

PMID34955658
PMCPMC8694406
OpenAlexW4200411185

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.